Nanobiotix to Present at HC Wainwright 26th Annual Global Investment Conference

PARIS and CAMBRIDGE, Mass., Sept. 3, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ”Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment options for cancer patients, today announced that the company’s management will participate in an informal meeting at the upcoming HC Wainwright 26^and Annual Global Investment Conference. See below for event details.

HC Wainwright 26^and Annual Global Investment Conference
Date: Wednesday, September 11, 2024
Time: 09:30 AM EDT / 15:30 PM CEST
Location: New York, NY
Speakers: Laurent Levy, Co-Founder of Nanobiotix and Chairman of the Board & Bart Van Rhijn, CFO of Nanobiotix
Webcast link: Click here